Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Walter E. Washington Convention Center

Jun 15, 2025 7:00 AM - Jun 19, 2025 3:00 PM

801 Allen Y. Lew Place, NW, Washington, DC 20001-3614, USA

DIA 2025 Global Annual Meeting

Project Orbis: Six Years Later

Session Chair(s)

Sema  Hashemi, MS

Sema Hashemi, MS

Senior International Policy Advisor, FDA, United States

In 2019, FDA’s OCE initiated Project Orbis to provide a framework for concurrent submission and review of oncology drug products. Project Orbis Partners will provide an update on their recent collaboration and answer questions from the audience.

Learning Objective : Discuss recent collaboration efforts beyond Project Orbis that were prompted by the initiative and explain how sponsors can benefit from participating in Project Orbis.

Speaker(s)

Sarah  Golding, MD

Panelist - Australia

Sarah Golding, MD

Senior Medical Officer - Oncology and Malignant Haematology Clinical Evaluation , Therapeutics Goods Administration, Australia

Marcelo  Moreira, MS

Panelist - Brazil

Marcelo Moreira, MS

GENERAL MANAGER, ANVISA, Brazil

Melissa  Hunt, MSc

Panelist - Canada

Melissa Hunt, MSc

Director, Health Canada, Canada

Michal  Hirsh-Vexberg, PharmD

Panelist - Israel

Michal Hirsh-Vexberg, PharmD

Head of the Pharmaceuticals Registration Department, Medical Technology, Health , Israel Ministry of Health, Israel

Anuradha  Poonepalli, PhD

Panelist - Singapore

Anuradha Poonepalli, PhD

Regulatory Consultant/Clinical Lead, Health Products Regulation Grou, Singapore HSA, Singapore

Ulrich Peter Rohr, DrMed

Panelist - Switzerland

Ulrich Peter Rohr, DrMed

Unit Head Clinical Review Hematology & Oncology, Swissmedic, Switzerland

Julian  Beach, MBA

Panelist - United Kingdom

Julian Beach, MBA

Interim Executive Director, Healthcare Quality and Access, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

R. Angelo  De Claro, MD

Panelist - United States

R. Angelo De Claro, MD

Director, Oncology Center of Excellence, FDA, United States

Dianne  Spillman

Panelist - United States

Dianne Spillman

Associate Director, Global and Regulatory Outreach, OCE, FDA, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.